Citigroup’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-37,926
Closed -$323K 7427
2013
Q3
$323K Buy
37,926
+2,486
+7% +$15.7K ﹤0.01% 3788
2013
Q2
$146K Buy
+35,440
New +$191K ﹤0.01% 4536

Citigroup's ASTX Position: Q4 2013 in Review

Citigroup sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 37,926 shares — an estimated $323K sold.

Citigroup first reported a position in ASTX in Q2 2013 and held it in 2 quarters. The position peaked at $323K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Citigroup reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Citigroup sold 37,926 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $323K.
  • Citigroup first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q2 2013 and held it in 2 quarters.
  • Citigroup's ASTEX PHARMACEUTICALS, INC COM position peaked at $323K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Citigroup's 13F filing for Q4 2013, filed 14 Feb 2014.